| 0 (0%) | 01-14 09:37 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 294.04 | 1-year : | 343.44 |
| Resists | First : | 251.75 | Second : | 294.04 |
| Pivot price | 207.54  |
|||
| Supports | First : | 182.24 | Second : | 139.27 |
| MAs | MA(5) : | 243.8 |
MA(20) : | 192.36 |
| MA(100) : | 141.88 |
MA(250) : | 90.19 |
|
| MACD | MACD : | 24.8 |
Signal : | 18.7 |
| %K %D | K(14,3) : | 96.1 |
D(3) : | 96.1 |
| RSI | RSI(14): 70.8 |
|||
| 52-week | High : | 251.75 | Low : | 27.15 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ KORU ] has closed below upper band by 25.2%. Bollinger Bands are 190.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 251.59 - 253.03 | 253.03 - 254.34 |
| Low: | 237.57 - 239.1 | 239.1 - 240.49 |
| Close: | 239.21 - 241.66 | 241.66 - 243.88 |
Tue, 13 Jan 2026
KORU Medical Systems’ preliminary net revenue up 23% in Q4 2025 - Medical Buyer
Tue, 13 Jan 2026
Koru Medical price target raised to $7 from $6.25 at Craig-Hallum - TipRanks
Mon, 12 Jan 2026
KORU Medical reports 23% revenue growth in Q4 2025 By Investing.com - Investing.com Australia
Mon, 12 Jan 2026
Koru Medical (KRMD) Exceeds Revenue Expectations for FY25 - GuruFocus
Tue, 06 Jan 2026
EXCLUSIVE VIDEO PREMIERE: Gavial Shares Their New Music Video for "Koru Mindset" - Ghost Cult Magazine
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|